EUVIMEDEUVIMED entdecken
Crossref

An optimized UPLC-MS/MS method for human plasma amyloid-β 42 and 40 measurement and application in Alzheimer's disease diagnosis

Qiaoxuan Zhang, Kai Bai, Xing Jin, Min Zhan, Liqiao Han, Junhua Zhuang, Xianzhang Huang

Journal of Pharmaceutical and Biomedical Analysis · 2024

DOI: 10.1016/j.jpba.2024.116396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2024. Verfasst von Qiaoxuan Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chine…. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Alzheimer Disease, Tandem Mass Spectrometry, Peptide Fragments. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Critical events in Alzheimer's disease (AD) involve an imbalance between the production and clearance of amyloid-β (Aβ) peptides from the brain. The ratio of Aβ42 to Aβ40 in plasma was useful for evaluating AD, but quantification is limited by factors including preanalytical analyte loss and insufficient sensitivity. The availability of a targeted UPLC-MS/MS method with adequate analytical sensitivity and accurate values traceable to the SI units is essential for implementing a strategy for assay standardization. A targeted UPLC-MS/MS method for plasma Aβ42 and Aβ40 quantification was developed based on selected characteristic peptides spiked by 15N-labeled Aβ. The calibrator was assigned using an amino acid analysis reference method trace to SI units. UPLC-MS/MS conditions and sample preparation procedures were assessed. 59 plasma samples comparison were used to evaluate immunoassays. Additionally, two clinical cohorts were selected for diagnostic performance evaluation. The LOQ of Aβ42 and Aβ40 is 10 pg mL-1 and 20 pg mL-1, respectively. The linear range was 10-500 pg mL-1 for Aβ42 and 20-1000 pg mL-1 for Aβ40, recoveries between 95.3 % and 108.2 % for Aβ42, 93.2 % and 104.1 % for Aβ40, imprecisions were

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-PeptidesAlzheimer DiseaseTandem Mass SpectrometryPeptide FragmentsHumansChromatography, High Pressure LiquidAgedMaleFemaleReproducibility of ResultsBiomarkersCalibrationAged, 80 and overLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

Alzheimer’s diseasePlasma amyloid βUPLC-MS/MS method

Substanzen

Amyloid beta-PeptidesPeptide Fragmentsamyloid beta-protein (1-42)amyloid beta-protein (1-40)Biomarkers

Autor:innen und Institutionen

  • Department of Laboratory Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China; State Key Laboratory of Dampness Syndr…
  • Department of Laboratory Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China; Second Clinical Medical College, Guang…
  • The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou 225009, China.
  • Department of Laboratory Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
  • Department of Laboratory Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China. Electronic address: huangxz020@163.com.

Zitieren

APA

Zhang, Q., Bai, K., Jin, X., Zhan, M., Han, L., Zhuang, J., & Huang, X. (2024). An optimized UPLC-MS/MS method for human plasma amyloid-β 42 and 40 measurement and application in Alzheimer's disease diagnosis. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2024.116396

Vancouver

Zhang Q, Bai K, Jin X, Zhan M, Han L, Zhuang J, et al. An optimized UPLC-MS/MS method for human plasma amyloid-β 42 and 40 measurement and application in Alzheimer's disease diagnosis. Journal of Pharmaceutical and Biomedical Analysis. 2024. doi:10.1016/j.jpba.2024.116396

BibTeX
@article{Zhang2024,
  author = {Zhang, Qiaoxuan and Bai, Kai and Jin, Xing and Zhan, Min and Han, Liqiao and Zhuang, Junhua and Huang, Xianzhang},
  title = {An optimized UPLC-MS/MS method for human plasma amyloid-β 42 and 40 measurement and application in Alzheimer's disease diagnosis},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2024},
  doi = {10.1016/j.jpba.2024.116396}
}
Kostenlos starten →